Gilead Sciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (457)

Latest Posts

About This Stock More About This Stock
Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy
Article By: Benzinga
Wednesday, June 3, 2020 11:50 AM EDT
Geoffrey Porges upgraded Gilead Sciences from Market Perform to Outperform and raised the price target from $85 to $94.
In this article: GILD Also: RCUS
Read
Gilead Falls After Phase 3 Remdesivir 10-Day Trial Failed To Reach Significance
Article By: Tyler Durden
Monday, June 1, 2020 9:50 AM EDT
The news sent ES futures lower, with the Emini down 8 points and Dow futures sliding back in the red.
In this article: GILD, DJI, SPX
Read
E Market Briefing For Monday, May 25
Article By: Gene Inger
Monday, May 25, 2020 12:11 AM EDT
Amidst the obvious backdrop the market forges ahead, with a 'Fed Put' as the driving force; and with what I call a handful of 'super-caps' at the helm; and a little better performance in so-called value sectors.
In this article: HTZ, GILD Also: DRI, NYA
Read
8 Monster Stocks To Watch For The Week Of May 25
Article By: Michael J. Kramer
Sunday, May 24, 2020 1:42 PM EDT
The market left itself in a vulnerable spot to start the final week of May. Trends overall are not all that bullish as the index continues to post signs of fading momentum.
In this article: AMD, QQQ, GILD, MSFT, NFLX, SPY, BABA, ROKU
Read
Are Biotech ETFs In Trouble As Coronavirus Dims Guidance?
Article By: Zacks Investment Research
Saturday, May 9, 2020 7:49 PM EDT
Although the coronavirus seems to be opening up opportunities for biotech companies, it is dampening their guidance as well. Despite impressive results, most of these biotechs have been seeing declining share prices since the earnings releases.
In this article: ALXN, IBB, AMGN, BIIB, GILD, BBH, XBI
Read

PARTNER HEADLINES

Latest Tweets for $GILD

No tweets yet!

$GILD

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kurt Benson 3/24/2017 10:12:59 PM

I have to agree with your assessment on $GILD. Do you know anything about $VBIO? I read a promising article here about their having a major breakthrough in #Crohn's research.

www.talkmarkets.com/.../interview-with-vitality-biopharma-inc

Not a lot of info on the company though.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Kirk Sheffield 3/24/2017 10:11:55 PM

I think $GILD will rebound. This isn't the only product they have in their pipeline.

Gilead Crohn's Treatment Is Not The Solution To GLD Revenue Issues
Alpha Stockman 3/24/2017 10:07:45 PM

I've been rather disappointed with #Gilead myself. After reading your article, I'm planning to offload some $GILD.

Gilead Sciences Receives Canadian Approval For HIV Drug
David Reynolds 2/20/2017 10:04:11 PM

The opening up of this market for #GileadSciences should bode well for the stock $GILD.

Gilead Sciences: Cheap Growth Or Value Trap?
Karen Klein 9/13/2016 5:39:48 PM

Excellent analysis, you have effectively convinced me to change my position on #Gilead. $GILD

3 Cult Stocks To Avoid In 2015
Bruce Powers 1/26/2015 8:01:06 AM

Great article and glad to read the reasoning to consider $GILD as a safer investment short, mid and long term.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 6:09:51 PM

Sorry all, thanks for the clarification. My bad! Now that I've read it through, it all makes total sense. $GILD, $BAC, $WFM, and $VA are my plays for 2015.

3 Cult Stocks To Avoid In 2015
BreakingBad News 1/25/2015 4:48:08 PM

I'd say this is a minority view, I've seen several others stating that $GILD was a stock to buy this year.

1 to 8 of 8 comments